Answer
Imlunestrant is contraindicated during breastfeeding because of the potential for serious adverse reactions in the breast-fed infant, although whether imlunestrant or its metabolites enter human milk is unknown.
Sources for this answer
- Inluriyo 200 mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked